Bright Minds Biosciences Inc. (CSE:DRUG)
93.03
-2.26 (-2.37%)
Jul 6, 2026, 12:18 PM EST
Bright Minds Biosciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $206.44 | Buy | Reiterates | $206.44 | +121.91% | Jun 25, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $270.51 → $313.22 | Buy | Reiterates | $270.51 → $313.22 | +236.69% | May 20, 2026 |
| Jefferies | Jefferies | Buy Initiates $206.44 | Buy | Initiates | $206.44 | +121.91% | Apr 12, 2026 |
| BTIG | BTIG | Buy Maintains $209.29 | Buy | Maintains | $209.29 | +124.97% | Mar 30, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $202.17 → $179.39 | Buy | Maintains | $202.17 → $179.39 | +92.83% | Feb 13, 2026 |
Unknown Analyst Chardan Capital No rating | Chardan Capital | Buy Initiates $113.90 | Buy | Initiates | $113.90 | +22.43% | Dec 31, 2025 |